Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, SMS Pharmaceuticals has informed that it enclosed invitation for Investor’s Conference Call, scheduled to be held on Friday, 26th May, 2023 at 11:00 am, IST, to discuss the Company’s financial performance for the fourth quarter and financial year ended 31st March, 2023.
The above information is a part of company’s filings submitted to BSE.